Former Prime Minister Imran Khan was shifted to Pakistan Institute of Medical Sciences in the early hours of February 24 for a scheduled follow-up eye procedure. Hospital officials confirmed that the 74-year-old underwent a second intravitreal injection as part of his ongoing treatment plan for a serious retinal condition.
According to the hospital administration, the injection was administered as a day-care surgical procedure under strict medical supervision. A board of specialists conducted a comprehensive examination of his affected eye before proceeding. Doctors have scheduled the third and final dose for March 23, depending on his recovery and response to treatment.
Security around the federal government hospital was significantly tightened prior to his arrival. Officials described the visit as a closely monitored medical movement. The procedure was carried out inside an operation theatre under controlled conditions, and authorities stated that all precautionary protocols were strictly followed throughout the intervention.
In addition to the ophthalmic procedure, his cardiac health was also evaluated as a precautionary measure. A consultant cardiologist performed echocardiography and an electrocardiogram (ECG). Hospital sources reported that both tests showed normal heart function, and his vital signs remained stable before, during, and after the medical process.
Following the treatment, he was discharged the same day after spending nearly an hour at the facility and was transported back to Adiala Jail with medical documentation and follow-up instructions. The development comes amid heightened political scrutiny over his health status and detention conditions.
A report submitted to the Supreme Court of Pakistan by Barrister Salman Safdar confirmed that he has been diagnosed with central retinal vein occlusion (CRVO), a potentially vision-threatening disorder linked to cardiovascular risk factors. Meanwhile, Pakistan Tehreek-e-Insaf criticized the hospital’s brief statement and demanded access for his personal doctors and family, citing concerns over transparency.
